Table 3.

Multivariate analyses evaluating the ability of clinico-biological variables to predict major outcomes at prostatectomy.

Pathological Characteristics	Serum PSA	Urinary PCA3 Score	Urinary T2 Score	PHI
Tumor volume
Univariate analysis	p = 0.240	p = 0.004	p = 0.025	p = 0.004
Multivariate analysis	-	p = 0.076	p = 0.249	p = 0.020
Gleason sum
Univariate analysis	p = 0.658	p = 0.922	p = 0.168	p = 0.028
Multivariate analysis	-	-	-	-
pT stage
Univariate analysis	p = 0.231	p = 0.328	p = 0.005	p = 0.038
Multivariate analysis	-	-	p = 0.026	p = 0.042
Multifocality
Univariate analysis	p = 0.704	p = 0.014	p = 0.413	p = 0.814
Multivariate analysis	-	-	-	-
Positive margins
Univariate analysis	p = 0.006	p = 0.580	p = 0.074	p = 0.003
Multivariate analysis	p = 0.357	-	-	p = 0.131

Abbreviations: PCA3: prostate cancer gene 3; PHI: Prostate Health Index; PSA: prostate-specific antigen; T2: TMPRSS2:ERG fusion gene.